• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期卵巢癌中ras癌基因产物p21的免疫组织化学检测。与临床结局缺乏相关性。

Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer. Lack of correlation with clinical outcome.

作者信息

Rodenburg C J, Koelma I A, Nap M, Fleuren G J

机构信息

Department of Pathology, Leiden University Hospital, The Netherlands.

出版信息

Arch Pathol Lab Med. 1988 Feb;112(2):151-4.

PMID:3276289
Abstract

The monoclonal antibody RAP 5 immunoreactive with the ras gene product p21 was used in an immunohistochemical study of 57 patients with advanced ovarian cancer and in 28 normal ovaries. The pattern of the staining of various tumor specimens was similar to the germinal epithelium of normal ovaries, whereas the intensity of staining was more enhanced in carcinomas than in normal ovaries. However, we found a lack of correlation among staining intensity of RAP 5 and the histologic type, the histologic grade, the ploidy class, and the clinical outcome.

摘要

与ras基因产物p21发生免疫反应的单克隆抗体RAP 5被用于对57例晚期卵巢癌患者和28个正常卵巢进行免疫组织化学研究。各种肿瘤标本的染色模式与正常卵巢的生发上皮相似,然而,癌组织中的染色强度比正常卵巢更强。但是,我们发现RAP 5的染色强度与组织学类型、组织学分级、倍体类别及临床结果之间缺乏相关性。

相似文献

1
Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer. Lack of correlation with clinical outcome.晚期卵巢癌中ras癌基因产物p21的免疫组织化学检测。与临床结局缺乏相关性。
Arch Pathol Lab Med. 1988 Feb;112(2):151-4.
2
[Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Sep;41(9):1409-16.
3
ras oncogene product p21 expression and prognosis of human ovarian tumors.
Gynecol Oncol. 1992 Jul;46(1):45-50. doi: 10.1016/0090-8258(92)90194-n.
4
Prophylactic oophorectomy: a morphologic and immunohistochemical study.预防性卵巢切除术:一项形态学和免疫组织化学研究。
Cancer. 2003 Dec 15;98(12):2599-606. doi: 10.1002/cncr.11848.
5
Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.脂肪酸合酶、凋亡调控基因、增殖因子及ras蛋白产物在大肠腺瘤、癌及相邻非肿瘤性黏膜中的免疫组化表达
Clin Cancer Res. 1999 Dec;5(12):4111-8.
6
Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.正常及二甲基肼处理大鼠结肠上皮中磷酸酪氨酸、p62 c-myc和p21 c-Ha-ras蛋白:免疫组织化学分析
Anticancer Res. 1995 Jan-Feb;15(1):211-8.
7
Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.在检测细胞角蛋白标记的肿瘤细胞后,通过流式细胞术对卵巢癌中DNA倍性和S期分数的预后意义进行多变量分析。
Gynecol Oncol. 2002 Jan;84(1):21-31. doi: 10.1006/gyno.2001.6440.
8
Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients.
Anticancer Res. 1995 Jul-Aug;15(4):1501-10.
9
Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.人卵巢未分化和高分化上皮癌中ras p21癌蛋白的免疫组织化学检测
Anticancer Res. 1995 Nov-Dec;15(6B):2847-50.
10
Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.卵巢颗粒细胞瘤和上皮性肿瘤中ras和B-raf基因的表达状态及突变分析
Gynecol Oncol. 2004 Dec;95(3):603-9. doi: 10.1016/j.ygyno.2004.07.062.

引用本文的文献

1
Prognostic significance of ras/p21 alterations in human ovarian cancer.RAS/P21改变在人类卵巢癌中的预后意义。
Br J Cancer. 1997;75(10):1547-53. doi: 10.1038/bjc.1997.264.
2
Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors.原癌基因ras p21蛋白在正常及肿瘤性喉组织中的表达:与组织病理学特征及表皮生长因子受体的相关性
Br J Cancer. 1994 Jun;69(6):995-9. doi: 10.1038/bjc.1994.195.
3
Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.
c-erbB-2、c-myc和c-ras癌蛋白、胰岛素样生长因子受体I以及表皮生长因子受体在卵巢癌中的表达
J Clin Pathol. 1994 Oct;47(10):914-9. doi: 10.1136/jcp.47.10.914.
4
C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy.C-myc癌基因产物P62c-myc在卵巢黏液性肿瘤中的表达:与恶性肿瘤相关的免疫组织化学研究
J Clin Pathol. 1989 Feb;42(2):148-52. doi: 10.1136/jcp.42.2.148.